Intrathecal Atropine Versus Intravenous Ondasetron in Post Operative Nausea Due to Intrathecal Morphine
- Registration Number
- NCT05137288
- Lead Sponsor
- Sohag University
- Brief Summary
To compare between intrathecal atropine versus preoperative administration of IV ondansetron in decreasing incidence of post operative nausea and vomiting related to intrathecal opioids in post operative period in perineal surgery as regard : efficacy and side effects .
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Age between ( 18 - 45 ) years.
- Body mass index between ( 18.5 - 35 )
- patients undergoing perineal surgery as anal fissure , piles and rectocele
- patients receiving bupivacaine ( 20 mg / 4 ml ) as spinal anesthesia
- Patinets with physical status 1 or 2 according to ASA classification
Exclusion Criteria
- Patient refusal .
- Any contraindication of neuraxial block as : coagulopathy , skin infection at injection site or bacteremia , hypovolemia and shock , history of allergy to L.A , sever aortic stenosis or mitral stenosis ......... etc
- Patients with physical status other than 1 and 2 according to ASA classification
- Those with history of nausea and vomiting , also those who received anti emetic drugs in last 2 hours of operation .
- Allergy to any of the drug included in this study .
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description patients receiving preoperative intravenous ondasetron Ondansetron , atropine and bupivacaine Patient received intrathecal hyperbaric bupivacaine ( 10 mg ) ( 2 ml 0.5% with 0.5 ml normal saline with morphine 250 mic ) with total volume = 2.5 ml with giving 4 mg IV ondansetron before anesthesia ( patients with body weight more than 80 Kg may need additional 4 mg IV ) . patients receiving intrathecal atropine Ondansetron , atropine and bupivacaine Patient received intrathecal hyperbaric bupivacaine ( 10 mg ) ( 2 ml 0.5% ) with morphine 250mic and atropine sulphate 100 micwith total volume = 2.5 ml .
- Primary Outcome Measures
Name Time Method frequency of attacks of postoperative nausea and vomiting 6-9 months Intrathecal atropine versus preoperative intravenous ondasetron for prevention of postoperative nausea and vomiting due to intrathecal morphine
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Sohag University Hospital
🇪🇬Sohag, Egypt